Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetes MellitusBlood GlucoseHypoglycemic AgentsHemoglobin A, GlycosylatedInsulinDiabetic NephropathiesDiabetic NeuropathiesDiabetes Mellitus, ExperimentalDiabetes ComplicationsCase-Control StudiesRisk FactorsObesityIslets of LangerhansMice, Inbred NODGlutamate DecarboxylaseDiabetes, GestationalHyperglycemiaDiabetic RetinopathyDiabetic AngiopathiesIslets of Langerhans TransplantationBlood Glucose Self-MonitoringHypoglycemiaPrediabetic StateRats, Inbred BBStreptozocinPregnancy in DiabeticsC-PeptideInsulin-Secreting CellsTime FactorsGenetic Predisposition to DiseasePancreas TransplantationHLA-DQ AntigensKidney TransplantationAlbuminuriaAutoantibodiesPancreasEchovirus 9Follow-Up StudiesBiological MarkersMetforminGlucose Tolerance TestTreatment OutcomeRetrospective StudiesGlucoseInsulin ResistanceBlood PressurePrevalenceBody Mass IndexGenotypeAutoimmune DiseasesCohort StudiesAutoimmunitySelf CarePolymorphism, Single NucleotideProspective StudiesCross-Sectional StudiesSulfonylurea CompoundsNuclear FamilyInsulin Infusion SystemsTransplantsAutoantigensCardiovascular DiseasesHypertensionDiabetes InsipidusHLA AntigensIncidenceAllelesDisease ProgressionGraft RejectionFastingPatient Education as TopicImmunosuppressive AgentsDiabetic FootComorbidityInfusions, SubcutaneousDiabetic KetoacidosisGraft SurvivalRisk AssessmentMultivariate AnalysisGlipizideGlucose IntoleranceDisease Models, AnimalPostprandial PeriodAge FactorsHistocompatibility TestingUnited StatesThiazolidinedionesQuestionnairesDiagnostic EquipmentNetherlandsLogistic ModelsInterferon Type IKidneyCells, CulturedGliclazideT-LymphocytesLipidsDisease Management